Stephen Dubner

Those blood pressure numbers are even worse today than they were when we first published this episode in 2020. Clearly, we still have not figured out how to get the science to the people who need it. Prescription adherence is a very difficult nut to crack.

Those blood pressure numbers are even worse today than they were when we first published this episode in 2020. Clearly, we still have not figured out how to get the science to the people who need it. Prescription adherence is a very difficult nut to crack.

Those blood pressure numbers are even worse today than they were when we first published this episode in 2020. Clearly, we still have not figured out how to get the science to the people who need it. Prescription adherence is a very difficult nut to crack.

You wouldn't think you'd have an adherence issue with something like the cochlear implant. It has such an obvious upside.

You wouldn't think you'd have an adherence issue with something like the cochlear implant. It has such an obvious upside.

You wouldn't think you'd have an adherence issue with something like the cochlear implant. It has such an obvious upside.

In one study, only half of the participants wore their device full-time.

In one study, only half of the participants wore their device full-time.

In one study, only half of the participants wore their device full-time.

Today on Freakonomics Radio, what to do about that very real issue, because you see the same thing not just in medicine, but in education and economic policy and elsewhere. Solutions that look foolproof in the research stage are failing to scale up.

Today on Freakonomics Radio, what to do about that very real issue, because you see the same thing not just in medicine, but in education and economic policy and elsewhere. Solutions that look foolproof in the research stage are failing to scale up.

Today on Freakonomics Radio, what to do about that very real issue, because you see the same thing not just in medicine, but in education and economic policy and elsewhere. Solutions that look foolproof in the research stage are failing to scale up.

We'll go in search of that magic sauce right after this.

We'll go in search of that magic sauce right after this.

We'll go in search of that magic sauce right after this.

John List is a pioneer in the relatively recent movement to give economic research more credibility in the real world.

John List is a pioneer in the relatively recent movement to give economic research more credibility in the real world.

John List is a pioneer in the relatively recent movement to give economic research more credibility in the real world.

Okay, so you and others moved experiments out of the lab and into the real world, but have you been able to successfully translate those experimental findings into, let's say, good policy?

Okay, so you and others moved experiments out of the lab and into the real world, but have you been able to successfully translate those experimental findings into, let's say, good policy?